AKT2/SIRT5/TFEB通路作为非新血管性AMD的潜在治疗标

Sayan Ghosh1, Ruchi Sharma2, Sridhar Bammidi1

  • 1Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Nature communications
|July 21, 2024
PubMed
概括

研究人员发现了一种新的AKT2/SIRT5/TFEB通路,对视网膜色素表皮的健康至关重要. 针对这种途径可能为与年龄相关的黄斑变性 (AMD) 提供一种新的治疗策略.